
Vapotherm VAPO
Quarterly report 2024-Q2
added 08-12-2024
Vapotherm DSO Ratio 2011-2025 | VAPO
Annual DSO Ratio Vapotherm
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.6 | 54.7 | 55.4 | 68.2 | 62.5 | 61.2 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 68.2 | 52.6 | 59.1 |
Quarterly DSO Ratio Vapotherm
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.7 | 49.8 | - | 49.2 | 49.3 | 45 | - | 27.4 | 34.9 | 43.9 | - | 35.1 | 49 | 52.5 | 52.4 | 70.1 | 61 | 75.7 | 57.8 | 69.6 | 62.8 | 56.9 | 55.5 | 69.1 | 61.4 | 30.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75.7 | 27.4 | 52.6 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
39.2 | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.86 | -3.26 % | $ 134 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 307.92 | -1.93 % | $ 8.69 B | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 45.13 | -2.67 % | $ 6.72 K | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
58.7 | $ 125.1 | 1.48 % | $ 218 B | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 92.34 | 0.64 % | $ 136 B | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 2.56 | 8.94 % | $ 95.5 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
OrthoPediatrics Corp.
KIDS
|
68.6 | $ 17.7 | -3.46 % | $ 408 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Xtant Medical Holdings
XTNT
|
64.4 | $ 0.73 | 4.33 % | $ 97.6 M | ||
|
InMode Ltd.
INMD
|
5.36 | $ 14.56 | 0.76 % | $ 1.15 B | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 9.88 | 0.05 % | $ 709 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
86.7 | $ 165.15 | 0.78 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
69.7 | $ 1.07 | -3.18 % | $ 110 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
46.1 | $ 12.81 | -1.23 % | $ 346 M | ||
|
FONAR Corporation
FONR
|
237 | $ 14.86 | -0.03 % | $ 97.4 M | ||
|
AxoGen
AXGN
|
48 | $ 30.33 | 1.15 % | $ 1.34 B | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
67 | $ 40.78 | 2.33 % | $ 1.26 B | ||
|
Globus Medical
GMED
|
76.9 | $ 86.83 | -2.31 % | $ 11.8 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 13.41 | -4.56 % | $ 1.03 B | ||
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
46.4 | $ 20.04 | 0.65 % | $ 2.86 B | ||
|
Aethlon Medical
AEMD
|
40.7 | $ 3.4 | - | $ 5.31 M | ||
|
Establishment Labs Holdings
ESTA
|
123 | $ 72.58 | -0.19 % | $ 2.04 B | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 0.92 | -4.72 % | $ 14.8 M | ||
|
Electromed
ELMD
|
137 | $ 29.74 | 0.64 % | $ 251 M | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 96.35 | -1.06 % | $ 1.22 B |